[at Seeking Alpha] – Gilead’s ( GILD ) reluctance to marry its Hep C drug Sovaldi with Bristol-Myers Squibb’s ( BMY ) daclatasvir forced Bristol to take evasive action. Bristol applied to the European Union for approval of …
Read more on … [visit site to read more]
- Stock Update: Biogen Idec Inc. (NASDAQ:BIIB) – [video] Biogen CEO: More products, company is focused
- Google Inc. (NASDAQ:GOOG) ~ HTC One KitKat update coming to Google Play edition smartphones
- Anadarko Petroleum Corporation (NYSE:APC) ~ Anadarko may sell China oil and gas project stakes, Reuters reports